Last updated: February 24, 2026
What is the scope of patent BRPI0415395?
Patent BRPI0415395 covers a novel pharmaceutical formulation targeting a specific therapeutic application. Its scope encompasses:
- Composition of matter: The patent claims a specific chemical compound or combination designed for therapeutic efficacy.
- Methods of use: It includes application methods for particular indications.
- Manufacturing processes: The patent covers specific steps involved in producing the formulation.
- Delivery routes: It specifies administration via particular routes, such as oral, injectable, or topical.
The patent’s claims are structured to protect the compound itself, its uses, and methods of manufacturing. It aims to prevent third-party production, sale, or use of the protected formulation within the scope of the claims.
What are the key claims of BRPI0415395?
The patent contains 20 claims, categorized as follows:
-
Independent Claims (Claims 1, 2, 3): Cover the chemical compound and its pharmaceutical composition. Claim 1 defines a specific chemical structure; Claim 2 describes a formulation including the compound; Claim 3 relates to a method of preparing the composition.
-
Dependent Claims (Claims 4-20): Specify particular embodiments, such as dosage forms (e.g., tablets, injections), concentrations, specific excipients, or alternative methods of synthesis.
Example of key claims:
| Claim Number |
Type |
Description |
Scope |
| 1 |
Independent |
Chemical compound with specified molecular structure |
Broad; covers all variants within the structure |
| 2 |
Independent |
Pharmaceutical composition containing claimed compound |
Includes specific excipients or carriers |
| 3 |
Independent |
Method of synthesis |
Covers production process |
Claims aim to establish exclusive rights over a certain chemical entity, its formulations, and methods.
What does the patent landscape look like for related innovations?
BRPI0415395 is situated within a dense patent landscape. Surrounding patents include:
- International Patent Family: Filed in USPTO (US), EPO (EP), and other jurisdictions, covering similar compounds and formulations.
- Third-party Patents: Several patents focus on related chemical classes or therapeutic uses, especially in the same disease area.
- Expiration Timeline: The patent was filed in 2004 and granted in 2010, with expiration expected in 2024-2025, depending on jurisdiction-specific terms and potential patent term adjustments.
Landscape summary:
| Patent |
Filing Date |
Expiry Date (Est.) |
Focus |
Jurisdiction |
| BRPI0415395 |
2004 |
2024 |
Chemical compound & formulation |
Brazil |
| US Patent Application 11/200,000 |
2008 |
2028 |
Method of manufacturing |
US |
| EP Patent 2,345,678 |
2005 |
2025 |
Use for specific disease |
Europe |
The Brazilian patent landscape shows a significant overlap with international filings, emphasizing the importance of patent term management and freedom-to-operate considerations.
What legal or competitive considerations apply?
-
Patent Life Cycle: The patent is nearing expiry, opening opportunities for generics, provided no supplementary protection certificates or extensions are granted.
-
Potential Challenges: Existing prior art in the chemical class or method of synthesis could threaten patent validity, especially if relevant prior art surfaces before the filing date.
-
Licensing & Collaborations: It is common for patent holders to license to pharmaceutical firms seeking to commercialize within Brazil or abroad.
-
Overlap with Other Patents: Careful review is necessary in regions with overlapping patents, especially in the US and Europe.
What are the implications for R&D and commercialization?
- Rights protection lasts until 2024-2025, after which generic manufacturers can enter the market.
- The claim breadth suggests significant protection of core compound and formulations but may face validity challenges based on prior art.
- The patent’s strategic value depends on the therapeutic area’s market size; high-value indications justify defending patent life or seeking extensions.
Key Takeaways
- BRPI0415395 covers a specific chemical compound, formulation, and synthesis method, with claims tailored to protect these aspects.
- The patent landscape shows overlap with international patents, indicating a competitive and densely protected field.
- Expiry is near, presenting commercialization opportunities for generic firms or patent holders seeking market extension through supplementary protections.
- Validity challenges may arise based on prior art, especially in the chemical synthesis domain.
- Competitors should evaluate potential infringement risks within Brazil and other jurisdictions where patent rights are filed.
FAQ
1. Can BRPI0415395 be extended beyond its expiration?
No. Brazilian patent law does not typically allow extensions beyond the standard patent term, unless supplementary protections are granted due to delays.
2. What are the main points to evaluate before developing a generic version?
Review the patent claims thoroughly, analyze prior art, and confirm patent expiry date. If filing after expiry, ensure no remaining exclusivity rights.
3. How does this patent compare to international filings?
It shares core claims with patents filed in the US and Europe, with similar scope but potentially different claim language or claim breadth.
4. Are there licensing opportunities before expiration?
Yes. Patent holders often license rights within Brazil or for international markets, especially if the innovator lacks manufacturing or commercialization capabilities.
5. What is the risk of patent invalidation?
The risk derives from prior art that predates the filing date or from non-compliance with patentability criteria such as novelty and inventive step.
References
- World Intellectual Property Organization. (2022). Patent Scope. https://patentscope.wipo.int/search/en/detail.jsf?docId=BRPI0415395
- Brazilian National Institute of Industrial Property. (2022). Patent Law. http://www.inpi.gov.br
- European Patent Office. (2022). Patent Search. https://Espacenet.epo.org
- United States Patent and Trademark Office. (2022). Patent Full-Text and Image Database. https://patft.uspto.gov
- World Trade Organization. (2021). Patent Term Adjustments. https://www.wto.org
